Lorlatinib in ROS1+ NSCLC With Brain Metastasis

Clinical trial NCT07083687 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07083687
Sponsor: Hunan Cancer Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer (NSCLC)

Start date: 2025-08-15
Primary completion: 2027-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.